BRAF and melanoma: To study the role of TERT in resistance to BRAFi and MEKi in BRAF-mutated melanoma, we overexpressed TERT in the BRAF-mutated melanoma cell line SkMel28, which expressed a low level of TERT due to a mutation at −57 bp in the TERT promoter (Figure 2C).